LOPINAVIR AND RITONAVIR

Trials studying LOPINAVIR AND RITONAVIR

• phase4A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatmentsrecruitingn=350
• phase2A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)not yet recruitingn=118
• phase3Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)completedn=195
• phase3Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primevacompletedn=105
• phase4A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimencompletedn=558
• phase2A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumorsrecruitingn=862
• —Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartumcompletedn=205
• phase4Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/rcompletedn=68